Responses
Regular and Young Investigator Award Abstracts
Novel Single-Agent Immunotherapies
1389 An assessment of ROR1 expression across tumor tissue and the investigation of a ROR1-targeted T cell engager as a therapeutic strategy to target ROR1 positive tumors
Compose a Response to This Article
Other responses
No responses have been published for this article.